ML-7

CAT: 0804-HY-119038Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-119038Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ML-7 is a myosin light chain kinase inhibitor with the activity to inhibit superoxide anion (O (2) (-) ) release in human neutrophils. ML-7 can affect the activity of neutrophils independently of myosin light chain kinase. ML-7 inhibits the extracellular O (2) (-) release of stimulated cells, but has no effect on the intracellular O (2) (-) production. ML-7 also strongly inhibits the binding of the intracellular compartment of oxide production to the cell membrane, indicating that it plays a key role in stimulated neutrophils. At the same time, ML-7 protects cardiac function from ischemia/reperfusion injury[1].
CAS Number
[109376-83-2]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ml-7.html
Smiles
O=S(N1CCNCCC1)(C2=C3C=CC=C(C3=CC=C2)I)=O
Molecular Formula
C15H17IN2O2S
Molecular Weight
416.28
References & Citations
[1]ML-7 inhibits exocytosis of superoxide-producing intracellular compartments in human neutrophils stimulated with phorbol myristate acetate in a myosin light chain kinase-independent manner
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products